
    
      Evaluation of toxicity and response of treatment with carboplatin and docetaxel to patients
      with epithelial cancer of ovary, fallopian tube or peritoneum with their first relapse
      occurring at least 6 months after end of first line treatment- Evaluation of toxicity
      according to Clinical Toxicity Criteria version 2.
    
  